Skip to content

Clinical trials

Phase 2 Multiple Myeloma trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2 Country / region: Turkey (Türkiye) Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20081
20091
20101
20121
20151
20163
20171
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen-Cilag International NV3
Janssen Research & Development, LLC2
Bristol-Myers Squibb1
Cellectar Biosciences, Inc.1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
European Society for Blood and Marrow Transplantation1
Novartis Pharmaceuticals1
Pharmacyclics Switzerland GmbH1
Stichting European Myeloma Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma14
Recurrence4
Neoplasms3
Bone Marrow Neoplasms2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Mantle-Cell2
Lymphoma, Non-Hodgkin2
Neoplasms, Plasma Cell2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.